药物与蛋白质相互作用导致眼部药物生物利用度改变。 - Suppr

Suppr

超能文献

Altered bioavailability of drugs in the eye due to drug-protein interaction.

作者信息

Mikkelson T J, Chrai S S, Robinson J R

出版信息

J Pharm Sci. 1973 Oct;62(10):1648-53. doi: 10.1002/jps.2600621014.

DOI:10.1002/jps.2600621014

PMID:4752109

Abstract

摘要

相似文献

Altered bioavailability of drugs in the eye due to drug-protein interaction.药物与蛋白质相互作用导致眼部药物生物利用度改变。

J Pharm Sci. 1973 Oct;62(10):1648-53. doi: 10.1002/jps.2600621014.

Competitive inhibition of drug-protein interaction in eye fluids and tissues.眼部体液和组织中药物与蛋白质相互作用的竞争性抑制

J Pharm Sci. 1973 Dec;62(12):1942-5. doi: 10.1002/jps.2600621207.

Biopharm Drug Dispos. 1982 Apr-Jun;3(2):115-28. doi: 10.1002/bdd.2510030205.

Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine.毛果芸香碱的眼部渗透：pH值对毛果芸香碱眼部渗透的影响。

Ann Ophthalmol. 1975 Feb;7(2):293-6.

Aqueous chamber drug distribution volume measurement in rabbits.

J Pharm Sci. 1977 Feb;66(2):219-24. doi: 10.1002/jps.2600660222.

Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.

J Pharm Sci. 1976 Sep;65(9):1295-301. doi: 10.1002/jps.2600650909.

Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.

J Pharm Sci. 1977 Sep;66(9):1222-8. doi: 10.1002/jps.2600660905.

A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.

J Pharmacokinet Biopharm. 1981 Dec;9(6):653-77. doi: 10.1007/BF01070899.

Overview of drug-protein binding.药物-蛋白质结合概述。

Ann N Y Acad Sci. 1973 Nov 26;226:6-17. doi: 10.1111/j.1749-6632.1973.tb20464.x.

Penetration routes of topically applied eye medications.

Am J Ophthalmol. 1978 Mar;85(3):383-6. doi: 10.1016/s0002-9394(14)77735-9.

引用本文的文献

Optimizing instilled drug delivery: a scoping review of microdrops in ophthalmology.优化滴眼剂给药：眼科微滴的范围综述

Graefes Arch Clin Exp Ophthalmol. 2025 Feb 26. doi: 10.1007/s00417-025-06773-1.

Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study.索拉非尼经脂质纳米粒用于眼部给药的重新利用：一项初步研究。

Pharmaceutics. 2021 Nov 18;13(11):1956. doi: 10.3390/pharmaceutics13111956.

The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.局部眼用药物在靶向眼后部方面的新作用

Ophthalmol Ther. 2021 Sep;10(3):465-494. doi: 10.1007/s40123-021-00365-y. Epub 2021 Jul 4.

Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.一种用于将索拉非尼眼部递送至眼后段的新型纳米结构微乳系统的评估。

Int J Mol Sci. 2021 Apr 22;22(9):4404. doi: 10.3390/ijms22094404.

Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs.泪膜中的白蛋白水平调节与医学相关的局部药物的生物利用度。

Front Pharmacol. 2020 Jan 28;10:1560. doi: 10.3389/fphar.2019.01560. eCollection 2019.

Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.口服泼尼松龙给药后犬有无结膜炎的泪液药代动力学。

J Ocul Pharmacol Ther. 2019 Jul/Aug;35(6):341-349. doi: 10.1089/jop.2019.0020. Epub 2019 May 9.

Computational modeling of drug transport across the in vitro cornea.药物经体外角膜转运的计算建模。

Comput Biol Med. 2018 Jan 1;92:139-146. doi: 10.1016/j.compbiomed.2017.11.009. Epub 2017 Nov 24.

Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.使用滴注后的扩散模型对β受体阻滞剂的眼部药代动力学进行表征。

Pharm Res. 1999 Oct;16(10):1596-601. doi: 10.1023/a:1018964823193.

Ocular pharmacokinetics of tobramycin. A comparative radioimmunoassay and microbiological assay.妥布霉素的眼药代动力学。一项比较放射免疫分析和微生物学分析。

Int Ophthalmol. 1993 Aug;17(4):201-10. doi: 10.1007/BF01007741.

Ocular and systemic bioavailability of ophthalmic flurbiprofen.眼科用氟比洛芬的眼部及全身生物利用度。

J Pharmacokinet Biopharm. 1984 Dec;12(6):611-26. doi: 10.1007/BF01059556.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验